CoreRx, Inc. completes acquisition of Societal CDMO, Inc. to enhance drug formulation and manufacturing capabilities
CoreRx, Inc. completes acquisition of Societal CDMO, Inc. to enhance drug formulation and manufacturing capabilities
04/08/24, 2:15 PM
Location
Industry
pharmaceutical
biotechnology
manufacturing
biotechnology
manufacturing
CoreRx, Inc. has successfully completed the acquisition of Societal CDMO, Inc., a contract development and manufacturing organization. This acquisition will enhance CoreRx's capabilities in drug formulation and GMP manufacturing, strengthening its position as an industry-leading CDMO.
Company Info
Location
Clearwater, Florida, United States
Company info
CoreRx, Inc. is an industry leading CDMO, providing innovative drug formulation, development, and GMP manufacturing to global pharmaceutical and biotech partners. CoreRx operates from two sites: its state-of-the-art campus in Clearwater, Florida and its Bend Bioscience campus in Bend, Oregon. CoreRx delivers value-added solutions to its partners focused on oral solids, liquids, and topicals, including enhanced formulations utilizing particle engineering-based drug delivery technologies and spray dry dispersion.